Evaluation of the commercial combined disk test and minimum inhibitory concentration (MIC) determination for detection of carbapenemase producers among Gram-negative bacilli isolated in a region with high prevalence of blaOXA-48 and blaNDM

International Microbiology : the Official Journal of the Spanish Society for Microbiology
Zoya HojabriOmid Pajand

Abstract

Carbapenem-resistant Gram-negative bacilli (GNB) are a concern in the Middle East and worldwide. Simple screening methods have been sought to detect carbapenemase producers to determine appropriate therapeutic measures and implement infection control interventions. In this study, we evaluated the efficiency of agar disc diffusion, commercial combined disc test (Rosco), and carbapenem MIC determination in comparison to molecular detection of carbapenemase genes among 82 carbapenem non-susceptible Enterobacteriaceae (CNSE) and 37 Acinetobacter/Pseudomonas isolates. The blaOXA-48, blaNDM, blaNDM/OXA-48, and blaIMP were detected in 68 out of 82 CNSE isolates. All of the Acinetobacter baumannii isolates were positive for the blaOXA-51 (n = 23), of those some were positive for blaOXA-48 (n = 13) and blaNDM (n = 3). Sensitivities and specificities of combined disc test for detection of blaNDM and blaOXA-48 carrying Enterobacteriaceae isolates were 92.5% and 100%, and 58.5% and 100%, respectively, while those for Acinetobacter/Pseudomonas isolates were 100%, 81.8% and 96.2%, 89%, respectively. While carbapenem MIC values had excellent concordance with phenotypic combined disc test for detection of blaOXA-48 producers (area under curve ...Continue Reading

References

Nov 15, 2005·The Journal of Antimicrobial Chemotherapy·Neil WoodfordMatthew J Ellington
Dec 21, 2007·Seminars in Respiratory and Critical Care Medicine·Andrea Endimiani, David L Paterson
Mar 15, 2011·Diagnostic Microbiology and Infectious Disease·Laurent PoirelPatrice Nordmann
Nov 26, 2011·Journal of Clinical Microbiology·Delphine GirlichPatrice Nordmann
Dec 6, 2011·International Journal of Antimicrobial Agents·Renu BharadwajYogesh Shouche
Jan 5, 2013·The Journal of Antimicrobial Chemotherapy·Zhiyong Zong, Xingzhuo Zhang
Mar 20, 2013·The Journal of Antimicrobial Chemotherapy·P BogaertsY Glupczynski
Jun 4, 2013·Diagnostic Microbiology and Infectious Disease·Mohammad Ahangarzadeh RezaeeZoya Hojabri
Aug 10, 2013·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·K van DijkJ W T Cohen Stuart
Jan 24, 2014·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·S PeterM Willmann
Feb 25, 2014·The Journal of Antimicrobial Chemotherapy·Zoya HojabriCaterina Mammina
May 3, 2014·BioMed Research International·Laurent DortetPatrice Nordmann
May 13, 2014·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·J HrabákC C Papagiannitsis
Sep 28, 2014·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·M KaziC Rodrigues
Aug 1, 2015·Journal of Clinical Microbiology·Alix PantelJean-Philippe Lavigne
Apr 30, 2016·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·A L M VlekUNKNOWN ISIS-AR study group
Jun 28, 2016·Expert Review of Anti-infective Therapy·Shelley Miller, Romney M Humphries
Nov 18, 2016·Microbial Drug Resistance : MDR : Mechanisms, Epidemiology, and Disease·Shirin BiglariBruno Silvester Lopes
Mar 20, 2018·Diagnostic Microbiology and Infectious Disease·Laurent DortetThierry Naas

❮ Previous
Next ❯

Citations

Apr 30, 2020·Microbial Drug Resistance : MDR : Mechanisms, Epidemiology, and Disease·Mohammad Javad NasiriPayam Tabarsi
Nov 25, 2020·The Annals of Pharmacotherapy·Kathleen C Blomquist, David E Nix
Jun 29, 2021·Frontiers in Medicine·Subhankar MukherjeeSulagna Basu

❮ Previous
Next ❯

Datasets Mentioned

BETA
KX249707

Methods Mentioned

BETA
PCR
electrophoresis

Related Concepts

Related Feeds

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Carbapenems (ASM)

Carbapenems are members of the beta lactam class of antibiotics and are used for the treatment of severe or high-risk bacterial infections. Discover the latest research on carbapenems here.

Carbapenems

Carbapenems are members of the beta lactam class of antibiotics and are used for the treatment of severe or high-risk bacterial infections. Discover the latest research on carbapenems here.

Acinetobacter Infections

Acinetobacter infections have become common in hospitalized patients, especially in the intensive care unit setting and are difficult to treat due to their propensity to develop antimicrobial drug resistance. Discover the latest research on Acinetobacter Infections here.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.